Precigen share price today

(PGEN)

Precigen share price is $0.76 & ₹64.58 as on 21 Dec 2024, 2.30 'hrs' IST

$0.76

▲

0.04

(5.07%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Precigen share price in Dollar and Rupees. Guide to invest in Precigen from India. Also see the sentimental analysis on Indian investors investing in Precigen. Get details on the Indian mutual funds that are investing in Precigen. Get Analyst recommendations and forecasts along with all the Precigen's financials.

Precigen share price movements

Today's Low: $0.71
Today's High: $0.77
$0.76
6.32%
Downside
Day's Volatility :7.78%
Upside
1.57%
52 Weeks Low: $0.65
52 Weeks High: $1.93
$0.76
14.3%
Downside
52 Weeks Volatility :66.25%
Upside
60.62%

Precigen Returns

Period	Precigen Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-24.73%	-12.2%	0.0%
6 Months	-54.92%	-6.9%	0.0%
1 Year	-42.4%	2.7%	0.0%
3 Years	-81.76%	-0.2%	-17.3%

Precigen Key Statistics

in dollars & INR

Previous Close	$0.7258
Open	$0.73
Today's High	$0.7721
Today's Low	$0.712
Market Capitalization	$208.7M
Today's Volume	$1.4M
52 Week High	$1.93
52 Week Low	$0.6513
Revenue TTM	$4.4M
EBITDA	$-88.6M
Earnings Per Share (EPS)	$-0.54
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-129.32%

How to invest in Precigen from India?

It is very easy for Indian residents to invest directly in Precigen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Precigen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Precigen or PGEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Precigen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Precigen shares which would translate to 1.118 fractional shares of Precigen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Precigen, in just a few clicks!

Returns in Precigen for Indian investors in Rupees

Investment Value

₹1,00,000

Precigen investment value today

Current value as on today

₹1,41,778

Returns

₹41,778

(+41.78%)

Returns from Precigen Stock

₹39,683 (false-39.68%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Precigen

-31%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Precigen on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -31% less investors are searching Precigen in the last 30 days versus the previous period.

Global Institutional Holdings in Precigen

Patients Capital Management LLC
6.12%
Adage Capital Partners Gp LLC
3.71%
BlackRock Inc
3.50%
Vanguard Group Inc
2.84%
Iridian Asset Management LLC
1.29%
Geode Capital Management, LLC
1.11%

Analyst Recommendation on Precigen

Buy

81%Buy

9%Hold

9%Sell

Based on 11 Wall street analysts offering stock ratings for Precigen(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Precigen

What analysts predicted

Upside of 689.47%

Current:

$0.76

Target:

$6.00

Insights on Precigen

Price Movement
In the last 7 days, PGEN stock has moved up by 7.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 717.0K → 953.0K (in $), with an average increase of 24.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -58.79M → -23.97M (in $), with an average increase of 145.2% per quarter
PGEN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 67.4%
PGEN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 102.2%
Price to Sales
ForPGEN every $1 of sales, investors are willing to pay $40.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Precigen Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$160.6M	↓ 30.48%
Net Income	$-509.3M	↑ 335.26%
Net Profit Margin	-317.2%	↓ 266.54%

	FY19	Y/Y Change
Revenue	$90.7M	↓ 43.5%
Net Income	$-207.8M	↓ 59.21%
Net Profit Margin	-229.0%	↑ 88.2%

	FY20	Y/Y Change
Revenue	$103.2M	↑ 13.73%
Net Income	$-103.8M	↓ 50.05%
Net Profit Margin	-100.58%	↑ 128.42%

	FY21	Y/Y Change
Revenue	$103.9M	↑ 0.67%
Net Income	$-96.8M	↓ 6.75%
Net Profit Margin	-93.16%	↑ 7.42%

	FY22	Y/Y Change
Revenue	$26.9M	↓ 74.09%
Net Income	$-79.8M	↓ 17.56%
Net Profit Margin	-296.47%	↓ 203.31%

	FY23	Y/Y Change
Revenue	$6.2M	↓ 76.87%
Net Income	$-95.9M	↑ 20.22%
Net Profit Margin	-1.5K%	↓ 1244.16%

	Q2 FY23	Q/Q Change
Revenue	$1.8M	↓ 4.54%
Net Income	$-20.3M	↓ 10.62%
Net Profit Margin	-1.1K%	↑ 78.28%

	Q3 FY23	Q/Q Change
Revenue	$16.7M	↑ 846.35%
Net Income	$87.4M	↓ 530.04%
Net Profit Margin	522.54%	↑ 1672.46%

	Q4 FY23	Q/Q Change
Revenue	$1.2M	↓ 92.66%
Net Income	$-33.1M	↓ 137.83%
Net Profit Margin	-2.7K%	↓ 3214.4%

	Q1 FY24	Q/Q Change
Revenue	$1.1M	↓ 13.27%
Net Income	$-23.7M	↓ 28.19%
Net Profit Margin	-2.2K%	↑ 462.94%

	Q2 FY24	Q/Q Change
Revenue	$717.0K	↓ 32.68%
Net Income	$-58.8M	↑ 147.67%
Net Profit Margin	-8.2K%	↓ 5970.8%

	Q3 FY24	Q/Q Change
Revenue	$953.0K	↑ 32.91%
Net Income	$-24.0M	↓ 59.22%
Net Profit Margin	-2.5K%	↑ 5683.67%

	FY18	Y/Y Change
Profit	$97.3M	↓ 42.16%

	FY19	Y/Y Change
Profit	$29.3M	↓ 69.86%

	FY20	Y/Y Change
Profit	$47.7M	↑ 62.56%

	FY21	Y/Y Change
Profit	$45.5M	↓ 4.57%

	FY22	Y/Y Change
Profit	$20.6M	↓ 54.78%

	FY23	Y/Y Change
Profit	$106.0K	↓ 99.48%

	Q2 FY23	Q/Q Change
Profit	$70.0K	↓ 78.4%

	Q3 FY23	Q/Q Change
Profit	$15.2M	↑ 21592.86%

	Q4 FY23	Q/Q Change
Profit	$-1.3M	↓ 108.82%

	Q1 FY24	Q/Q Change
Profit	$-810.5K	↓ 39.47%

	Q2 FY24	Q/Q Change
Profit	$-297.0K	↓ 63.36%

	Q3 FY24	Q/Q Change
Profit	$-56.0K	↓ 81.14%

	FY18	Y/Y Change
Operating Cash Flow	$-124.2M	↑ 19.3%
Investing Cash Flow	$-151.2M	↓ 244.93%
Financing Cash Flow	$309.8M	↑ 7131.44%

	FY19	Y/Y Change
Operating Cash Flow	$-135.9M	↑ 9.41%
Investing Cash Flow	$86.9M	↓ 157.44%
Financing Cash Flow	$8.1M	↓ 97.37%

	FY20	Y/Y Change
Operating Cash Flow	$-77.0M	↓ 43.34%
Investing Cash Flow	$27.8M	↓ 68.02%
Financing Cash Flow	$32.7M	↑ 301.88%

	FY21	Y/Y Change
Operating Cash Flow	$-55.8M	↓ 27.59%
Investing Cash Flow	$-74.5M	↓ 368.33%
Financing Cash Flow	$121.2M	↑ 270.55%

	FY22	Y/Y Change
Operating Cash Flow	$-65.0M	↑ 16.63%
Investing Cash Flow	$226.4M	↓ 403.75%
Financing Cash Flow	$-155.3M	↓ 228.14%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-15.8M	↓ 14.25%
Investing Cash Flow	$23.5M	↓ 146.63%
Financing Cash Flow	$-14.6M	↓ 133.02%

Precigen Technicals Summary

Sell

Neutral

Buy

Precigen is currently in a neutral trading position according to technical analysis indicators.

Precigen Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Precigen Inc	-13.25%	-54.92%	-42.4%	-81.76%	-87.96%
Regeneron Pharmaceuticals, Inc.	-4.72%	-33.43%	-16.35%	14.7%	89.27%
Biontech Se	9.01%	28.55%	5.71%	-57.13%	220.59%
Alnylam Pharmaceuticals, Inc.	-3.99%	7.16%	25.05%	27.48%	103.59%
Vertex Pharmaceuticals Incorporated	-12.1%	-16.49%	-2.12%	78.05%	80.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Precigen Inc	NA	NA	NA	-0.46	-1.29	-0.42	NA	0.48
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.05	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Precigen Inc	Buy	$208.7M	-87.96%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	89.27%	17.67	33.61%
Biontech Se	Buy	$26.8B	220.59%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.7B	103.59%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$115.2B	80.31%	32.84	-4.51%

About Precigen

precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua

Organization	Precigen
Employees	202
CEO	Mr. Randal J. Kirk J.D.
Industry	Health Technology

Management People of Precigen

Name	Title
Mr. Randal J. Kirk J.D.	Executive Chairman
Dr. Helen Sabzevari MPH, Ph.D.	President, CEO & Director
Mr. Harry Thomasian Jr.	Chief Financial Officer
Mr. Rutul R. Shah	Chief Operating Officer
Mr. Donald P. Lehr J.D., Ph.D.	Chief Legal Officer & Corporate Secretary
Mr. Jeffrey Thomas Perez J.D.	Senior Vice President of Intellectual Property Affairs
Mr. Steven Harasym	VP & Head of Investor Relations
Mr. Rob Russell	VP & Head of Human Resources
Dr. Douglas E. Brough Ph.D.	Senior VP & Head of Research
Dr. Bryan T. Butman Ph.D.	Senior VP & Head of CMC

Important FAQs about investing in Precigen from India :

What is Precigen share price today?

Precigen share price today stands at $0.76, Open: $0.73 ; Previous Close: $0.73 ; High: $0.77 ; Low: $0.71 ; 52 Week High: $1.93 ; 52 Week Low: $0.65. The stock opens at $0.73, after a previous close of $0.73. The stock reached a daily high of $0.77 and a low of $0.71, with a 52-week high of $1.93 and a 52-week low of $0.65.

Can Indians buy Precigen shares?

Yes, Indians can invest in the Precigen (PGEN) from India.

With INDmoney, you can buy Precigen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Precigen at zero transaction cost.

How can I buy Precigen shares from India?

It is very easy to buy Precigen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Precigen be purchased?

Yes, you can buy fractional shares of Precigen with INDmoney app.

What are the documents required to start investing in Precigen stocks?

To start investing in Precigen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.